3D Systems, a company that engineers, manufactures and sells 3D printers, 3D printing materials, 3D scanners, and offers a 3D printing service, agreed to acquire Volumetric Biotechnologies, a Houston-based biotech company, for up to $400m. "The addition of Dr. Miller and his exceptional team of researchers to our existing Team, led by our Chief Technology Officer for Regenerative Medicine, Chuck Hull, will dramatically expand our capabilities and capacity for the development of bioprinted human organs," Jeffrey Graves, 3D Systems President and CEO.